AUTHOR=Curiel Cid Rosie E. , Ortega Alexandra , Crocco Elizabeth A. , Hincapie Diana , McFarland Karen N. , Duara Ranjan , Vaillancourt David , DeKosky Steven T. , Smith Glenn , Sfakianaki Efrosyni , Rosselli Monica , Barker Warren W. , Adjouadi Malek , Barreto Yarlenis , Feito Yuleidys , Loewenstein David A. 

TITLE=Semantic intrusion errors are associated with plasma Ptau-181 among persons with amnestic mild cognitive impairment who are amyloid positive

JOURNAL=Frontiers in Neurology

VOLUME=Volume 14 - 2023

YEAR=2023

URL=https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2023.1179205

DOI=10.3389/fneur.2023.1179205

ISSN=1664-2295

ABSTRACT=Semantic intrusion errors (SI) have distinguished between those with amnestic Mild Cognitive Impairment (aMCI) who are amyloid positive (A+) versus negative (A-) on positron emission tomography (PET). This study examines the association between SI and plasma -based biomarkers. One hundred and twenty-eight participants received SiMoA derived measures of plasma pTau-181, ratio of two amyloid-β peptide fragments (Aβ42/Aβ40), Neurofilament Light protein (NfL), Glial Fibrillary Acidic Protein (GFAP), ApoE genotyping, and amyloid PET imaging. The aMCI A+ (n=42) group had a higher percentage of ApoE ɛ4 carriers, and greater levels of pTau-181 and SI, than Cognitively Unimpaired (CU) A-participants (n=25). CU controls did not differ from aMCI A-(n=61) on plasma biomarkers or ApoE genotype. Logistic regression indicated that ApoE ɛ4 positivity, pTau-181, and SI were independent differentiating predictors (Correct classification=82.0%; Sensitivity=71.4%; Specificity=90.2%) in identifying A+ from A-aMCI cases. A combination of plasma biomarkers, ApoE positivity and SI had high specificity in identifying A+ from A-aMCI cases.